Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Patent tenofovir alafenamide gilead?What is the difference between apixaban and apixaban accord?Is januvia still on the market?Symbravo medication information ema europa eu?How much is mebendazole?
See the DrugPatentWatch profile for Trijardy
Trijardy XR (empagliflozin/linagliptin/metformin) was FDA-approved on September 18, 2020 [1].
Trijardy XR is a fixed-dose combination tablet that contains empagliflozin, linagliptin, and metformin [1].
You can confirm the approval date in the FDA’s drug-approval record for Trijardy XR on Drugs@FDA [1].
[1] https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212854
Other Questions About Trijardy :